tetrabenazine - CISMeF

Preferred Label : tetrabenazine;

MeSH definition : A drug formerly used as an antipsychotic and treatment of various movement disorders. Tetrabenazine blocks neurotransmitter uptake into adrenergic storage vesicles and has been used as a high affinity label for the vesicle transport system.;

CISMeF synonym : orphan brand of tetrabenazine; tetrabenazine orphan brand; cambridge laboratories brand of tetrabenazine; shire brand of tetrabenazine; roche brand of tetrabenazine;

MeSH hyponym : nitoman; xenazine;

MeSH CAS label : 2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-;

MeSH Related Number : 58-46-8 (Tetrabenazine);

Registry Number MeSH : 58-46-8;

Wikipedia link : https://en.wikipedia.org/wiki/Tetrabenazine;

Codes EINECS : 200-383-6;

Is substance : O;

UNII : Z9O08YRN8O;

InChIKey : MKJIEFSOBYUXJB-HOCLYGCPSA-N;

Details

Origin ID

D013747;

UMLS CUI

C0039623;

ATC code(s)
- tetrabenazine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Tetrabenazine poisoning (disorder) [SNOMED CT concept]
- tetrabenazine [Substance BNPC]
Pharmacological action(s)
- adrenergic uptake inhibitors [MeSH Descriptor]
Record concept(s)
- nitoman [MeSH concept]
- tetrabenazine [MeSH concept]
- xenazine [MeSH concept]
Related MeSH Supplementary Concept(s)
- (11C)-(+)-alpha-dihydrotetrabenazine [MeSH Supplementary Concept]
- 2-N-((3'-iodo-4'-azidophenyl)propionyl)tetrabenazine [MeSH Supplementary Concept]
- 5-O-methyldihydrotetrabenazine [MeSH Supplementary Concept]
- 9-benzyloxy-alpha-dihydrotetrabenazine [MeSH Supplementary Concept]
- 9-fluoroethyldihydrotetrabenazine [MeSH Supplementary Concept]
- N-(3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo(a)quinolizin-2-yl)-4-((4-azido-2-nitrophenyl)amino)butanamide [MeSH Supplementary Concept]
- deutetrabenazine [MeSH Supplementary Concept]
- dihydrotetrabenazine [MeSH Supplementary Concept]
- florbenazine F 18 [MeSH Supplementary Concept]
- valbenazine [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Product containing tetrabenazine (medicinal product) [SNOMED CT concept]
- Tetrabenazine [ICD-11 Extension code]
- Tetrabenazine [NCIt concept]
- Tetrabenazine (substance) [SNOMED CT concept]
- tetrabenazine [ATC Code]
- tetrabenazine [Substance BNPC]
Validated automatic mappings to BTNT
- tetrabenazine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients